Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Azacitidine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Azacitidine 100mg powder for suspension for injection vials
0801030ACAAAAAA
|
Azacitidine | Azacitidine | Malignant Disease and Immunosuppression | No data available |
|
Azacitidine 150mg powder for suspension for injection vials
0801030ACAAACAC
|
Azacitidine | Azacitidine | Malignant Disease and Immunosuppression | No data available |
|
Vidaza 100mg powder for suspension for injection vials
0801030ACBBAAAA
|
Vidaza | Azacitidine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.